Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diagnostic Imaging | 14 | 2026 | 274 | 3.720 |
Why?
|
| Liver Neoplasms | 8 | 2024 | 309 | 1.650 |
Why?
|
| Radiology | 11 | 2025 | 263 | 1.580 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2024 | 175 | 1.450 |
Why?
|
| Crohn Disease | 4 | 2021 | 108 | 1.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2019 | 128 | 0.980 |
Why?
|
| Liver Cirrhosis | 2 | 2017 | 184 | 0.910 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 367 | 0.880 |
Why?
|
| Pancreatic Neoplasms | 2 | 2019 | 354 | 0.860 |
Why?
|
| Upper Extremity Deep Vein Thrombosis | 1 | 2022 | 5 | 0.710 |
Why?
|
| Pulmonary Embolism | 2 | 2020 | 198 | 0.710 |
Why?
|
| Thoracic Wall | 1 | 2022 | 23 | 0.690 |
Why?
|
| Societies, Medical | 11 | 2026 | 401 | 0.690 |
Why?
|
| Vena Cava Filters | 1 | 2020 | 23 | 0.640 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2026 | 1665 | 0.630 |
Why?
|
| Delirium | 1 | 2020 | 55 | 0.620 |
Why?
|
| Practice Guidelines as Topic | 5 | 2015 | 741 | 0.600 |
Why?
|
| Psychotic Disorders | 1 | 2020 | 150 | 0.580 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 154 | 0.560 |
Why?
|
| Evidence-Based Medicine | 8 | 2026 | 464 | 0.550 |
Why?
|
| Medical Oncology | 1 | 2019 | 70 | 0.550 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 135 | 0.500 |
Why?
|
| Neoplasm Staging | 7 | 2025 | 553 | 0.500 |
Why?
|
| Fatty Liver | 1 | 2017 | 115 | 0.490 |
Why?
|
| United States | 15 | 2026 | 8190 | 0.470 |
Why?
|
| Contrast Media | 7 | 2026 | 435 | 0.470 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2025 | 2324 | 0.470 |
Why?
|
| Gastroenterology | 1 | 2015 | 29 | 0.450 |
Why?
|
| Mass Screening | 2 | 2019 | 700 | 0.440 |
Why?
|
| Humans | 40 | 2026 | 65826 | 0.440 |
Why?
|
| Radiology Information Systems | 2 | 2024 | 37 | 0.420 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 502 | 0.410 |
Why?
|
| Diagnosis, Differential | 6 | 2025 | 995 | 0.400 |
Why?
|
| Jaundice | 1 | 2013 | 6 | 0.390 |
Why?
|
| Colorectal Neoplasms | 4 | 2023 | 290 | 0.380 |
Why?
|
| Cholestasis | 1 | 2013 | 65 | 0.370 |
Why?
|
| Postoperative Complications | 1 | 2019 | 1336 | 0.350 |
Why?
|
| Rectal Neoplasms | 2 | 2025 | 139 | 0.310 |
Why?
|
| Prognosis | 4 | 2019 | 1792 | 0.310 |
Why?
|
| Colonic Neoplasms | 2 | 2023 | 220 | 0.280 |
Why?
|
| Urinary Tract | 1 | 2026 | 11 | 0.240 |
Why?
|
| Hemospermia | 1 | 2025 | 1 | 0.230 |
Why?
|
| Wounds, Penetrating | 1 | 2026 | 33 | 0.230 |
Why?
|
| Pelvis | 1 | 2026 | 64 | 0.230 |
Why?
|
| Abdominal Injuries | 1 | 2026 | 32 | 0.230 |
Why?
|
| Cystitis | 1 | 2005 | 10 | 0.220 |
Why?
|
| Urinary Tract Infections | 1 | 2026 | 97 | 0.220 |
Why?
|
| Gastrointestinal Diseases | 1 | 2005 | 69 | 0.210 |
Why?
|
| Hydrotherapy | 1 | 2004 | 2 | 0.210 |
Why?
|
| Pneumoperitoneum | 1 | 2004 | 4 | 0.210 |
Why?
|
| Chronic Disease | 2 | 2017 | 745 | 0.210 |
Why?
|
| Hemangioendothelioma, Epithelioid | 1 | 2004 | 7 | 0.200 |
Why?
|
| Graft vs Host Disease | 1 | 2005 | 113 | 0.200 |
Why?
|
| Lung Diseases | 1 | 2005 | 183 | 0.190 |
Why?
|
| Venous Thrombosis | 1 | 2004 | 113 | 0.190 |
Why?
|
| Appendicitis | 2 | 2015 | 84 | 0.190 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2004 | 185 | 0.180 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2005 | 357 | 0.180 |
Why?
|
| Abdominal Pain | 3 | 2015 | 99 | 0.170 |
Why?
|
| Chest Pain | 1 | 2022 | 86 | 0.170 |
Why?
|
| Lower Extremity | 1 | 2022 | 160 | 0.160 |
Why?
|
| Prostate-Specific Antigen | 1 | 2019 | 84 | 0.140 |
Why?
|
| Pneumonia, Viral | 1 | 2021 | 220 | 0.130 |
Why?
|
| Colonography, Computed Tomographic | 2 | 2014 | 20 | 0.120 |
Why?
|
| Anticoagulants | 1 | 2020 | 529 | 0.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 92 | 0.120 |
Why?
|
| Liver Diseases | 1 | 2017 | 157 | 0.110 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 526 | 0.110 |
Why?
|
| Positron Emission Tomography Computed Tomography | 3 | 2023 | 63 | 0.110 |
Why?
|
| Barium Sulfate | 1 | 2014 | 17 | 0.110 |
Why?
|
| Enema | 1 | 2014 | 14 | 0.100 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2023 | 102 | 0.100 |
Why?
|
| Radiography | 2 | 2005 | 559 | 0.090 |
Why?
|
| Radiation Effects | 1 | 2011 | 3 | 0.090 |
Why?
|
| Preoperative Care | 1 | 2012 | 199 | 0.090 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 327 | 0.080 |
Why?
|
| Sensitivity and Specificity | 4 | 2023 | 1172 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5830 | 0.070 |
Why?
|
| Male | 7 | 2025 | 31398 | 0.070 |
Why?
|
| Pregnancy | 4 | 2026 | 2402 | 0.070 |
Why?
|
| Female | 9 | 2026 | 34414 | 0.060 |
Why?
|
| Ultrasonography | 3 | 2017 | 491 | 0.060 |
Why?
|
| Iodine Radioisotopes | 1 | 2006 | 60 | 0.060 |
Why?
|
| Dandy-Walker Syndrome | 1 | 2006 | 1 | 0.060 |
Why?
|
| Deoxycytidine | 1 | 2006 | 45 | 0.060 |
Why?
|
| Fluorouracil | 1 | 2006 | 68 | 0.060 |
Why?
|
| Placenta Diseases | 1 | 2005 | 9 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2006 | 87 | 0.060 |
Why?
|
| Placenta | 1 | 2005 | 73 | 0.060 |
Why?
|
| Diagnostic Errors | 1 | 2006 | 106 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2025 | 102 | 0.050 |
Why?
|
| Intestinal Obstruction | 1 | 2005 | 54 | 0.050 |
Why?
|
| Abdomen | 1 | 2005 | 97 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 1 | 2004 | 43 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2005 | 84 | 0.050 |
Why?
|
| Digestive System Diseases | 1 | 2004 | 14 | 0.050 |
Why?
|
| Phlebography | 1 | 2004 | 45 | 0.050 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2004 | 18 | 0.050 |
Why?
|
| Respiratory Tract Diseases | 1 | 2004 | 40 | 0.050 |
Why?
|
| Recurrence | 1 | 2026 | 665 | 0.050 |
Why?
|
| von Willebrand Factor | 1 | 2004 | 10 | 0.050 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2004 | 16 | 0.050 |
Why?
|
| Antigens, CD34 | 1 | 2004 | 53 | 0.050 |
Why?
|
| Angiography | 1 | 2004 | 154 | 0.050 |
Why?
|
| Middle Aged | 4 | 2006 | 18491 | 0.050 |
Why?
|
| Musculoskeletal Diseases | 1 | 2004 | 105 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2004 | 96 | 0.050 |
Why?
|
| Ischemia | 1 | 2005 | 203 | 0.050 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2004 | 202 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2004 | 178 | 0.050 |
Why?
|
| Nervous System Diseases | 1 | 2004 | 109 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2004 | 186 | 0.040 |
Why?
|
| Radiologists | 1 | 2023 | 95 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2023 | 233 | 0.040 |
Why?
|
| Algorithms | 1 | 2024 | 1060 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 6953 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 712 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2017 | 6 | 0.030 |
Why?
|
| Time Factors | 1 | 2005 | 3778 | 0.030 |
Why?
|
| Multidetector Computed Tomography | 1 | 2017 | 22 | 0.030 |
Why?
|
| Adolescent | 2 | 2006 | 6367 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2004 | 876 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 692 | 0.030 |
Why?
|
| Appendix | 1 | 2015 | 17 | 0.030 |
Why?
|
| Child | 1 | 2004 | 4653 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2011 | 2113 | 0.030 |
Why?
|
| Acute Disease | 1 | 2015 | 664 | 0.020 |
Why?
|
| Adult | 3 | 2006 | 17567 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2011 | 29 | 0.020 |
Why?
|
| Abdomen, Acute | 1 | 2011 | 23 | 0.020 |
Why?
|
| Radiation Protection | 1 | 2011 | 27 | 0.020 |
Why?
|
| Adenoma | 1 | 2010 | 70 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2010 | 97 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2010 | 76 | 0.020 |
Why?
|
| Biopsy | 1 | 2010 | 463 | 0.020 |
Why?
|
| Survival Rate | 1 | 2010 | 847 | 0.020 |
Why?
|
| Aged | 1 | 2004 | 15141 | 0.020 |
Why?
|
| Dihydrouracil Dehydrogenase (NADP) | 1 | 2006 | 3 | 0.020 |
Why?
|
| Thyroglobulin | 1 | 2006 | 9 | 0.020 |
Why?
|
| Thymidine Phosphorylase | 1 | 2006 | 4 | 0.020 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2006 | 35 | 0.020 |
Why?
|
| Capecitabine | 1 | 2006 | 14 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2006 | 42 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2006 | 50 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 223 | 0.010 |
Why?
|
| Fetus | 1 | 2006 | 103 | 0.010 |
Why?
|
| Radiographic Image Enhancement | 1 | 2005 | 99 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2006 | 205 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2006 | 1441 | 0.010 |
Why?
|